Skip to main content
Clinical Trials/NCT05890157
NCT05890157
Not Yet Recruiting
N/A

Treatment Of Shallow Periodontal Pockets Using PRF As an Adjunct To Scaling And Root Planing In Periodontitis Patients, Randomized Clinical Trial

University of Baghdad0 sites12 target enrollmentJuly 30, 2023
ConditionsPeriodontitis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Periodontitis
Sponsor
University of Baghdad
Enrollment
12
Primary Endpoint
Change in Periodontal pocket depth measured in mm
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Platelet rich fibrin (PRF) has been widely used in regenerative dentistry since it provides plenty amount of growth factors that enhance wound healing and tissue regeneration. Platelet derived growth factor-BB (PDGF-BB) is a growth factor with essential functions such as regulation of cell migration, proliferation, and differentiation. This study aims to evaluate the efficacy of PRF in improving the clinical periodontal parameters and GCF level of PDGF-BB.

Detailed Description

Split mouth randomized clinical trial is the design of the study. 12 periodontitis patients with 24 opposite shallow periodontal pockets (4-6 mm in depth) will be selected. Randomization in this study will be achieved using toss of coin method in which periodontal pockets will be designated either control site or test site. PRF will be used as an adjunct to scaling and root planing to treat the test sites. While control sites were treated by scaling and root planing only. Clinal periodontal parameters were recorded and GCF level of PDGF-BB will be measured at baseline and1- and 3- month follow-up visits to evaluate the healing response to the treatment.

Registry
clinicaltrials.gov
Start Date
July 30, 2023
End Date
December 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sarah Alrihaymee

Principal Investigator

University of Baghdad

Eligibility Criteria

Inclusion Criteria

  • periodontitis

Exclusion Criteria

  • Periodontal therapy for the last 3 months
  • Medical history of systemic diseases such as diabetes.
  • Patients wearing dental prosthesis
  • Alcoholic patients
  • Teeth with grade II mobility, endodontic lesions, and teeth with untreated caries

Outcomes

Primary Outcomes

Change in Periodontal pocket depth measured in mm

Time Frame: Change from baseline to 1-month and change from baseline to 3-month

Using UNC-15 periodontal probe measured in mm

Change in Clinical attachment level

Time Frame: Change from baseline to 1-month and change from baseline to 3-month

Using UNC-15 periodontal probe measured in mm

Secondary Outcomes

  • Change in plaque index(Change from baseline to 1-month and change from baseline to 3-month)
  • Change in bleeding on probing percentage(Change from baseline to 1-month and change from baseline to 3-month)
  • Change in GCF level of platelet derived growth factor(Change from baseline to 1-month and change from baseline to 3-month)

Similar Trials